Burlington, MA, September 26, 2016: On Thursday September 15th, the CNES’s (Centre National d’Etudes Spatiales) Cardiospace mission was launched from China’s Jiuquan Satellite Launch Center aboard the new TianGong-2 orbital module. The France-China Cardiospace will be studying how astronauts’ cardiovascular system adapts to microgravity conditions and is deconditioned on their return to Earth. Terason is honored that our advanced technology was chosen as the scanner of choice for this important mission.
The new TianGong-2 orbital module was launched Thursday September 15th from China’s Jiuquan Satellite Launch Center, this time carrying a broader range of devices including Cardiospace, a joint effort of CNES and CMSEO/ACC (China Manned Space Engineering Office/Astronaut Center of China).
Cardiospace is designed to study how the cardiovascular system adapts during human spaceflight. Its results will of course benefit astronaut health but also public health, as cardiovascular diseases are the number one cause of mortality worldwide. CNES coordinated development of the instruments making up Cardiospace, in particular Terason’s Doppler laser and ultrasound scanner that will measure micro-circulation and macro-circulation. The intuitive nature of the Terason 3200 system, coupled with the lightweight, small footprint and crystal clear imagery will yield a wealth of science data that could serve to determine new joint space missions for China’s future space station.
Since mid-June, Cardiospace has been undergoing ground trials as part of a 180-day confinement experiment organized by ACC in Beijing and SISC (Space Institute of South China) in Shenzhen. It will be used on the orbital module for about one month by the two taikonauts assigned to fly on the ShenZhou-11 mission, which will be launching and then docking with TianGong-2 in mid-October.
As an industry pioneer, Terason is committed to delivering unprecedented customer satisfaction and quality products with the latest in technology and developments in ultrasound imaging available today. The new proprietary uSmart products provide exceptional imaging capability and the advanced technology, features and functionality users have come to expect from Terason. These complete ultrasound solutions optimize workflow, enhance clinical efficacy, and increase productivity for everyday clinical needs. This commitment further expands to improving healthcare around the world, providing diagnostic capabilities to those otherwise unable to receive care. Terason will continue to strive to exceed expectations and industry standards, and provide customers with the latest advancements in portable ultrasound.
Terason, a division of Teratech Corporation began in 1994, drawing upon technology developed at MIT’s Lincoln Laboratory. Dr. Alice Chiang, CEO and Chairman of the Board, founded the company to apply developments in the fields of radar, sonar, and telecommunications technologies to the demanding requirements of battlefield ultrasound. Recognizing that decades of breakthrough research for the Department of Defense could be applied to the challenges of mainstream ultrasound imaging, she formed the Terason division. With initial key patents protecting the integrated circuit technology she developed at MIT, Dr. Chiang dedicated Terason to the development of a micro-miniaturized commercial ultrasound system.
Today, we continue to revolutionize ultrasound with developments in high-performance portable systems. For more information, visit www.terason.com.
Susan BoschettoDirector of Global Marketing, Terason1-781-270-4143/p>